Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection

참고문헌 (6)

1. McHutchison JG, "Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection", N Engl J Med, 361, pp.580~593 (2009)
2. 박상훈, "Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study", Gut and Liver, 6(1), pp.98~106 (2012), 거트앤리버 발행위원회
3. European Association for Study of Liver, "EASL clinical practice guidelines: management of hepatitis C virus infection", J Hepatol, 60, pp.392~420 (2014)
4. Herrmann E, "The kinetics of hepatitis C virus", Eur J Gastroenterol Hepatol, 18, pp.339~342 (2006)
5. Yuki Wada, "Prediction of a Null Response to Pegylated Interferon α-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C", Gut and Liver, 8(4), pp.421~427 (2014), 거트앤리버 발행위원회
6. Reau N, "Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C", Am J Gastroenterol, 106, pp.452~458 (2011)

관련 논문AI추천